Related Experiment Video
Updated: Jun 25, 2025
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Mg-ZIF nanozymes disrupt the level of ROS for osteosarcoma killing via POD activity
Junjie Zheng1, Shiqiang Zhuo1, Lin Huang1
1Department of Orthopedics, Shanghai Sixth People's Hospital Fujian, Luoshan Section, Quanzhou, China.
Abstract:
Osteosarcoma (OS) is notorious for its high malignancy, and conventional chemotherapy drugs, while killing tumor cells, often inflict significant harm on the patient's body. The tumor microenvironment of OS is characterized by high levels of hydrogen peroxide (H2O2). Leveraging this feature, we have developed Mg-ZIF nanoparticles, which incorporate magnesium (Mg) to confer robust peroxidase (POD)-like enzymatic activity. These Mg-ZIF nanozymes can generate highly lethal superoxide anions within tumor cells in a responsive manner, thereby achieving effective tumor destruction. Both in vitro and in situ OS models have corroborated the anti-tumor efficacy of Mg-ZIF nanozymes, while also validating their biosafety. The design of Mg-ZIF nanozymes opens a new avenue for the treatment of OS, offering a promising therapeutic strategy.
Insights
Mg-ZIF nanozymes harness tumor microenvironment’s hydrogen peroxide to generate lethal superoxide anions, effectively destroying osteosarcoma (OS) cells. This novel approach demonstrates potent anti-tumor efficacy and biosafety in preclinical models.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Osteosarcoma (OS) presents high malignancy with conventional chemotherapy causing significant patient harm.
- The OS tumor microenvironment is characterized by elevated hydrogen peroxide (H₂O₂) levels.
Purpose of the Study:
- To develop a novel therapeutic strategy for osteosarcoma using nanozymes.
- To leverage the unique tumor microenvironment of OS for targeted cancer treatment.
Main Methods:
- Development of magnesium-infused ZIF (Mg-ZIF) nanoparticles with peroxidase (POD)-like activity.
- Utilizing Mg-ZIF nanozymes to generate superoxide anions in response to H₂O₂ within tumor cells.
- Evaluation of anti-tumor efficacy and biosafety in both in vitro and in situ osteosarcoma models.
Main Results:
- Mg-ZIF nanozymes exhibited robust POD-like enzymatic activity.
- Responsive generation of lethal superoxide anions within tumor cells led to effective tumor destruction.
- Preclinical studies confirmed the anti-tumor efficacy and biosafety of Mg-ZIF nanozymes.
Conclusions:
- Mg-ZIF nanozymes offer a promising new therapeutic avenue for osteosarcoma treatment.
- This strategy effectively targets osteosarcoma by exploiting its tumor microenvironment.
- The developed nanozymes demonstrate significant potential for safe and effective cancer therapy.
